Although the study of germ cell death is arguably still in its infancy as a field, several recent breakthroughs have provided the fodder for a story, replete with episodes of apparent mass cellular suicide if not murder, that will undoubtedly serve as a research base for many laboratories over the next several years. Death is known to strike the male and female germlines with roughly equal intensity, but the innate feature of male germ cells being self-renewing while those of the female are not places the death of oocytes in a completely different light. Indeed, the functional life span of the female gonads is defined in most species, including humans, by the size and rate of depletion of the precious endowment of oocytes enclosed within follicles in the ovaries at birth. This continuous loss of oocytes throughout life, referred to by many as the female biological clock, appears to be driven by a genetic program of cell death that is composed of players and pathways conserved from worms to humans. It is on this genetic pathway, and the role of its constituent molecules in regulating female germ cell fate, that this review will focus. Emphasis will be placed on those studies using genetic-null or transgenic models to explore the functional requirement of proteins, such as Bcl-2 family members, Apaf-1, and caspases in vertebrates to CED-9, CED-4, and CED-3 in Caenorhabditis elegans, in oocyte survival and death. Furthermore, hypotheses regarding the potential impact of translating what is now known of the oocyte death pathway into new approaches for the clinical diagnosis and management of female infertility and the menopause will be offered as a means to stimulate further research in this new and exciting field.
INTRODUCTION: HOURGLASSES, OOCYTES, AND THE FEMALE BIOLOGICAL CLOCK
The hourglass. An old-fashioned but reliable device for monitoring the passage of time. Once inverted, each grain of sand flows through a narrow opening separating the upper and lower reservoirs, seemingly by a random process. However, in each hourglass the number of sand grains is carefully calculated to provide 60 minutes of time before the upper reservoir irreversibly (unless, of course, inverted once again) empties its contents into the lower portion of the timepiece. In many respects, female germ cells can be considered analogous to grains of sand within an hourglass in that the continuous trickle of oocytes out of the initial endowment provided at birth in most, if not all, vertebrate species functions as the "female biological clock" (Fig. 1) . Once the oocyte reserve has been exhausted, ovarian senescence, driving what is referred to as the menopause in women, rapidly ensues. However, unlike the passage of sand through an hourglass, the size of the oocyte reserve set forth at birth (in other words, the number of sand grains initially deposited in the upper reservoir), as well as the rate of oocyte loss from the ovaries throughout postnatal life (or, how quickly the sand passes from the upper to lower reservoirs), can be modified with dramatic consequences on the fertile life span and overall well-being of females as they age (Fig. 1) . Accordingly, this represents one of the major themes to be evaluated herein.
Although depletion of the female germ cell reserve throughout life is in itself not a particularly novel concept, the involvement of apoptosis and its regulatory molecules in this process represents a relatively new and certainly very exciting research initiative. Much of the work reported over the past few years with respect to the mechanisms underlying oocyte loss has stemmed from a rapidly accumulating volume of data derived from assessments of apoptosis in other model systems, including powerful genetic studies of cell death in the Caenorhabditis elegans hermaphrodite and Drosophila (Hengartner, 1996; McCall and Steller, 1997; Bergmann et al., 1998; Metzstein et al., 1998) . These observations have collectively provided a molecular map of a cell death program, remarkably conserved through evolution, that now serves to guide developmental and reproductive biologists in designing experiments necessary to delineate the genetics and biochemistry of oocyte apoptosis. Moreover, the recent availability of mice lacking key components of this conserved cell death program has proved instrumental for substantiating many correlative gene expression studies in that certain molecules have been identified as indispensable for female germ cell survival or for death to proceed. This article will therefore attempt to summarize our current understanding of the events responsible for initiating oocyte apoptosis and will hypothesize how this information may one day be used to alter the rate by which the female biological clock ticks.
BIOCHEMISTRY AND GENETICS OF CELL DEATH: HOW THE CLOCK TICKS?
As a preface for the discussions to come, this section will briefly overview apoptosis and its constituent molecules (for more in-depth reviews on this topic, the reader is referred to Adams and Cory, 1998; Ashkenazi and Dixit, 1998; Green, 1998; Green and Reed, 1998; Minn et al., 1998; Thornberry and Lazebnik, 1998; Vaux and Korsmeyer, 1999) . In it most simplistic form, apoptosis can be broken down into four stages, the first of which is receipt by the cell of a potentially lethal stimulus (Fig. 2) . These stimuli come in many forms, both physiological and pathological. In those instances of normal cell turnover, the two primary inputs leading to apoptosis are active induction via exposure to death-promoting members of the Fas ligand (also referred to as CD95 or APO-1)/tumor necrosis factor-␣ superfamily (Nagata, 1997; Ashkenazi and Dixit, 1998; Peter and Krammer, 1998) or "death by neglect" resulting from inadequate levels of key survival/growth factors (Raff, 1992; Conlon and Raff, 1999) . Interestingly, many pathological insults, such as cancer therapies (chemical and radiation) and environmental toxicants, can also trigger apoptosis (Eastman, 1993; Verheij et al., 1998) , a concept that has raised much attention in recent years and is of particular relevance to the topic at hand (see "Premature Ovarian Failure" below and Tilly, 1998a) .
The second stage of apoptosis is the recruitment of early intracellular signaling molecules that relay the plethora of external information received by the cell to a central regulatory checkpoint for interpretation (i.e., the third stage) governed primarily by the Bcl-2 family of proteins (Fig. 2) . The second messengers utilized by each cell vary depending upon the type and magnitude (dose and duration) of stimulus received and include molecules derived from both gene expression (e.g., p53, Ko and Prives, 1996; Ding and Fisher, 1998; kinases, Verheij et al., 1996; Datta et al., 1997; Kennedy et al., 1997) and cellular metabolism (e.g., ceramide, Hannun, 1996; Kolesnick and Kronke, 1998; sphingosine 1-phosphate, Spiegel et al., 1998 ; reactive oxygen species, Hampton et al., 1998) . Integration of the information provided by these signals into a final decision for cellular life or death is then made at the level of the mitochondrion, the primary intracellular site of Bcl-2 family member localization and function (Green and Reed, 1998) .
The bcl-2 protooncogene was first identified from the chromosomal translocation event t(14;18)(q32;21), characteristic of certain B-cell lymphomas, that juxtaposed the immunoglobulin heavy chain enhancer/promoter adjacent to the Bcl-2 coding sequence (Bakhshi et al., 1985; Cleary and Sklar, 1985; Tsujimoto et al., 1985) . The oncogenic potential of Bcl-2 overexpression in this context was later identified as being the result of the ability of the protein to convey resistance to apoptosis in the face of growth factor withdrawal (Vaux et al., 1988) , a mechanism of action that has since been enumerated many times over regardless of
FIG. 1.
Analogy drawn between the loss of oocytes via apoptosis and the trickling of grains of sand through an hourglass to define the female biological clock. In the upper reservoir, each grain of sand can be considered a healthy oocyte. Just as the number of grains of sand in the upper reservoir of an hourglass is calculated to provide an hour of time before all of the sand passes to the lower reservoir, the rate at which healthy oocytes pass irrevocably into the apoptotic pool (due to prenatal germ cell attrition, postnatal follicular atresia, or exposure of the ovary to pathologic insults) defines how long the female biological clock will tick. Importantly, the rate at which the healthy oocyte reserve is decimated by apoptosis is precisely controlled by a number of molecules that comprise an evolutionarily conserved cell death program (see Figs. 2 and 3).
the initiating stimulus for cell death (Korsmeyer, 1998; Reed, 1998) . The vertebrate Bcl-2 family now consists of at least 16 members Korsmeyer, 1998; Minn et al., 1998; Reed, 1998) , subdivided as antiapoptotic (e.g., Bcl-2, Bcl-x L , Mcl-1, A1, Bcl-w, NR-13) or proapoptotic (e.g., Bax, Bcl-x S , Bad, Bak, Bid, Bik/Blk, Bim, Hrk, Bok/ Mtd), with one new member with expression almost restricted to the ovary remaining controversial in terms of function (Diva or Boo; Inohara et al., 1998; Song et al., 1999) .
The characterization of Bcl-2, the founding member of the family, as a protein that for the most part functions to prevent apoptosis provided the first link to a now wellestablished genetic program of cell death conserved between invertebrate and vertebrate species (Fig. 3) . The most frequently studied model of cell death in invertebrates is the C. elegans hermaphrodite, in which 131 of the 1090 somatic cells formed during development of the nematode undergo programmed death (Ellis et al., 1986 (Ellis et al., , 1991 Hengartner, 1996; Metzstein et al., 1998) . Inactivating mutations in the ced-9 gene of C. elegans leads to massive cell death and embryonic lethality (Hengartner, 1996; Metzstein et al., 1998) , implying that the CED-9 protein encodes a molecule similar to Bcl-2 with respect to func-
FIG. 2.
Schema of events that define four general stages of apoptosis induction and execution. The first stage is receipt by the cell of a potentially lethal stimulus, which then activates one or more early signaling molecules during stage 2. These immediate-early signals are relayed into the central regulators at stage 3 for integration in which the final decision for life or death is made. If apoptosis is to be the outcome, the fourth stage comprising the effector molecules required to dismantle the cell is activated through a molecular bridge protein (Apaf-1) coupled to Bcl-2 family member function (mitochondrial stability and cytochrome c release) at stage 3. Abbreviations used that are not defined in the text: Fas L , Fas ligand; TNF␣, tumor necrosis factor-␣; PI3K, phosphatidylinositol 3Ј-kinase; S1P, sphingosine 1-phosphate; PKC, protein kinase C; SAPKs, stress-activated protein kinases; Cyt-c, cytochrome c; AIF, apoptosis-inducing factor; DFF45, DNA fragmentation factor-45; CAD, caspase-activated DNase.
FIG. 3.
Evolutionary conservation of the cell death program from worms to humans. Upon receipt by the cell of a lethal stimulus, the intracellular death pathway is activated in both C. elegans (left) and vertebrates (right) by suppression of CED-9/Bcl-2-like survival function. This can occur either directly or indirectly via induction of proapoptotic cytoplasmic signals (Egl-1/Hrk-like molecules) that can antagonize CED-9/Bcl-2-like action. Once CED-9/Bcl-2-like function is repressed, activation of CED-4/Apaf-1 occurs, leading to induction of CED-3/caspases as final executioners of the cell death program. Molecules in green boxes are antiapoptotic, whereas those in red boxes are proapoptotic.
tion. Cloning of the ced-9 gene revealed significant structural similarity with bcl-2 as well (Hengartner and Horvitz, 1994) , data further supported by the findings that Bcl-2 can substitute for CED-9 to partially restore cellular survival in ced-9 Ϫ/Ϫ animals (Vaux et al., 1992) . More recently, a molecule somewhat analogous to proapoptotic members of the Bcl-2 family containing only the BH3 domain (e.g., Hrk, Bad, Bim, Bid), termed Egl-1, has emerged in C. elegans as a negative regulator of CED-9 function (Conradt and Horvitz, 1998; del Peso et al., 1998) , further establishing the similarities in cell death regulation between invertebrates and vertebrates (Fig. 3) .
Many functions of Bcl-2 family members have been ascribed over the years (Reed, 1994) , but one mechanism in particular, i.e., the pivotal role of mitochondria as integrators of Bcl-2 family function as well as a source of proapoptotic factors (Green and Reed, 1998) , has gained the acceptance of many in the field as the principal means by which these proteins probably regulate activation of the fourth and final stage of apoptosis involving the effector or "executioner" molecules ( Fig. 2) . Several members of the Bcl-2 protein family exhibit subcellular localization to mitochondrial membranes (Hockenberry et al., 1990; GonzalezGarcia et al., 1994; Wang and Studzinski, 1997; Hegde et al., 1998; Motoyama et al., 1998) , and in the case of Bax, this proapoptotic molecule translocates from the cytosol to mitochondria upon exposure of the cell to an apoptotic stimulus (Wolter et al., 1997; Gross et al., 1998) . A similar cytosolic-to-mitochondrial relocalization has been described for the proapoptotic protein Bid, although cleavage of Bid to a truncated form is required for its mitochondrial insertion (Gross et al., 1999) . Parallel studies published 2 years ago (Kluck et al., 1997; Yang et al., 1997) demonstrated that Bcl-2 directly blocks mitochondrial cytochrome c release and the subsequent activation of caspases (a family of cysteine aspartic acid-specific proteases that dismantle the cell during the execution or effector stage of apoptosis; Cryns and Yuan, 1998; Thornberry and Lazebnik, 1998) . These observations have since been extended to a second antiapoptotic Bcl-2 family member, Bcl-x L (Jü rgensmeier et al., 1998) . In contrast, both Bax and truncated Bid cause a rapid destabilization of mitochondria and release of cytochrome c followed by caspase activation in both intact cells and cell-free assays (Jü rgensmeier et al., 1998; Li et al., 1998; Luo et al., 1998; Gross et al., 1999) .
The exact role of cytochrome c in caspase activation, however, remained elusive until the purification and cloning of a protein termed Apaf-1 (Zou et al., 1997) , isolated as part of a trimeric protein complex that could reconstitute procaspase processing and apoptotic events in cell-free assays (hence, the original names given to these proteins were apoptotic protease-activating factors or Apaf-1, -2, and -3). The other two proteins of this complex were identified as cytochrome c (Apaf-2) and caspase-9 (Apaf-3) (Li et al., 1997; Zou et al., 1997) . Using a number of biochemical approaches, Wang and co-workers methodically dissected the actions and interactions of each component of the Apaf trimer in caspase activation. Their results, combined with additional new data from other laboratories, have served as the basis for the following model of apoptosis execution (Green, 1998; Green and Reed, 1998) . Release of cytochrome c from mitochondria, an event directly regulated by Bcl-2 family members, produces a conformational change in Apaf-1, allowing for heterodimeric interaction of the protein with procaspase-9. The resulting interaction generates procaspase-9 oligomers, leading to auto-or transcatalytic processing of the precursor enzyme to fully functional caspase-9 . Once activated, caspase-9 then initiates a proteolytic cascade by sequential activation of other death effector caspases, most notably caspase-3 (Green, 1998) .
This model is important for two reasons. First, it provides the critical communication bridge between stage 3 (regulators) and stage 4 (effectors) of apoptosis (Fig. 2) . Second, the cloning of Apaf-1 revealed evolutionary conservation with a key proapoptotic molecule in C. elegans, termed CED-4 (Hengartner, 1996; Metzstein et al., 1998) , that functions downstream of CED-9 to activate a cysteine protease referred to as CED-3 (Fig. 3 ). Functional inactivation of CED-4 or CED-3 in C. elegans results in survival of the 131 somatic cells normally destined for deletion during development (Hengartner, 1996; Metzstein et al., 1998) , arguing that these two proteins are indeed required for programmed cell death in the nematode. Moreover, the ced-3 gene product represents the fourth example discussed herein of a protein whose structure and cell death-regulatory function have been conserved through evolution based on its striking structural and functional similarities with a caspase homolog in Drosophila (Song et al., 1997) and caspases in vertebrates (Cryns and Yuan, 1998; Thornberry and Lazebnik, 1998) . Therefore, analogous to the linear functional relationship between CED-9, CED-4, and CED-3 in regulating cell death in C. elegans, Apaf-1 couples Bcl-2 protein family function (regulation of mitochondrial cytochrome c release) to caspase function (processing of procaspase-9 and activation of death effector caspases) in the apoptotic cell death program in vertebrates (Fig. 3) . Of final note in this section, another putative vertebrate CED-4 homolog, termed FLASH, has recently been cloned and appears to function specifically in the Fas-mediated pathway of apoptosis (Imai et al., 1999) . While the functional role of FLASH in various paradigms of apoptosis in the body remains to be established, these data nonetheless indicate that, like the existence of multiple CED-9 and CED-3 homologs identified in chordates to date, there will be a growing family of CED-4 homologous proteins in vertebrates as well.
PRENATAL FEMALE GERM CELL DEATH: THE HOURGLASS IS INVERTED
In the mouse embryo, primordial germ cells (PGC) of both sexes can be first identified posterior to the primitive streak on day 7.5 of gestation (e7.5). After migration from the allantois through the developing hindgut mesentery to the developing genital ridges, the PGC initiate their developmental programs of oogenesis or spermatogenesis (Eddy et al., 1981; Ginsburg et al., 1990; Wylie, 1999) . Similar patterns of PGC development and migration have been identified in many animal species, including the chick (Fujimoto et al., 1976) and Drosophila (Warrior, 1994) , and considerable research effort has been expended to elucidate the control of PGC survival during these early stages of embryogenesis. However, with the focus of this review being oocyte death, the reader is referred elsewhere for discussions of PGC fate (Buehr, 1997; Pesce et al., 1997; Tilly, 1998b) .
Most of the research efforts directed at understanding the occurrence and regulation of oocyte apoptosis have been conducted with vertebrate model systems, and thus it is on chordates that this review will primarily focus. However, two recent reports, one from work in Drosophila (McCall and Steller, 1998) and another from studies of C. elegans (Gumienny et al., 1999) , offer potential new models to explore the genetics of cell death during invertebrate oogenesis and thus will be commented on in detail later in this article. In the developing mouse fetus, PGC that have colonized the developing ovaries (the germ cells are now referred to as oogonia) continue to proliferate and thus expand the female germline. Peak numbers of germ cells are reached by around e13.5, at which time many of the oogonia have left the mitotic cell cycle and initiated the first steps of meiosis (Byskov, 1986) . After passing through the leptotene, zygotene, pachytene, and diplotene stages of meiosis I, the oocytes become arrested in diakinesis coincident with their enclosure by a specialized population of somatic (pregranulosa) cells to form primordial follicles (Byskov, 1986 ). An identical situation is believed to proceed in human fetal ovaries (Briggs et al., 1999) , with peak germ cell numbers of around 7 ϫ 10 6 reached by approximately the 20th week of gestation (Baker, 1963; Tilly and Ratts, 1996) .
However, in all vertebrate species examined to date, females are born with far fewer oocytes than the peak numbers present during early oogenesis. In fact, it has been estimated that over two-thirds of the potential female germ cell pool is lost by the time of birth in rats (Beaumont and Mandl, 1961) , mice (Borum, 1961; Bakken and McClanahan, 1978) , and humans (Pinkerton et al., 1961; Baker, 1963; Forabosco et al., 1991) , resulting from attrition of both oogonia and oocytes (Borum, 1961; Bakken and McClanahan, 1978) . Using a wide variety of techniques, including morphological assessments (Pesce and De Felici, 1994; De Pol et al., 1997; Morita et al., 1999a) , fluorescence-activated cell sorting (Coucouvanis et al., 1993) , and DNA fragmentation assays (Ratts et al., 1995; De Pol et al., 1997; Morita et al., 1999a) , several laboratories have independently confirmed the involvement of apoptosis in this paradigm of developmental cell death. Therefore, it can be argued that aging of the ovary (in effect, ticking of the female biological clock), if defined by germ cell depletion via a physiological death process, begins even before the animal is born (Fig. 1) .
ENDOCRINE-REGULATED CELL DEATH DURING OOGENESIS: DEFINING THE SIZE OF THE UPPER RESERVOIR
Early genetic analyses (Mintz and Russell, 1957) revealed gonadal dysgenesis and sterility in male and female mice that lack functional expression of stem cell factor (SCF, also referred to as the Steel locus gene product) or its receptor, c-kit (also referred to as the W or dominant white-spotting locus gene product). These observations support a number of subsequent reports that SCF, acting via c-kit, is a primary growth and survival factor for murine PGC (De Felici and Dolci, 1991; Matsui et al., 1991; Dolci et al., 1993; and oocytes (Packer et al., 1994; Morita et al., 1999a) . However, SCF is probably only one of many endocrine factors involved in regulating germ cell fate during female gonadal development. For example, leukemia inhibitory factor (LIF) has been identified as a potent survival factor for murine PGC (De Felici and Dolci, 1991; Matsui et al., 1991; Dolci et al., 1993; Pesce et al., 1993) and a critical component needed for the antiapoptotic benefits provided by SCF in the fetal ovarian germ cell pool (Morita et al., 1999a) . These in vitro culture observations are, however, not supported by genetic evidence since knockout of LIF does not result in impaired gonadal development or fertility problems in mice of either sex, albeit subtle uterine defects related to implantation failure were occasionaly seen in female mice (Stewart et al., 1992) . It may be that ligand activation of gp130, the high-affinity receptor for LIF, is accomplished in LIF-null (and, perhaps, wild-type) mice through other factors, such as oncostatin M, that are known to also bind gp130 and thus mimic the actions of LIF on PGC (Koshimizu et al., 1996; Hara et al., 1998) . These findings, taken with additional data that indicate roles for interleukin-4 (PGC, Cooke et al., 1996) , basic fibroblast growth factor (PGC, Matsui et al., 1992) , tumor necrosis factor-␣ (PGC, Kawase et al., 1994) , Gas 6 (PGC, Matsubara et al., 1996) , insulin-like growth factor-I (IGF-I) (oogonia/ oocytes, Morita et al., 1999a) , retinoic acid (PGC, Koshimizu et al., 1995; oogonia/oocytes, Morita and Tilly, 1999) , and transforming growth factor-␤ (PGC, Godin and Wylie, 1991; oogonia/oocytes, Morita et al., 1999a) in gametogenesis as well, suggest that the endocrine control of oogonium and oocyte fate during fetal ovarian development is likely to be extremely complex (Fig. 4) .
Very little is currently known of the intracellular effectors utilized by the ligand-activated hormone receptors that provide anti-or proapoptotic signals in germ cells. In many somatic cell lineages, survival factor-promoted activation of phosphatidylinositol 3Ј-kinase (PI3K) appears to be critical for the suppression of apoptosis (for examples, see Franke et al., 1995; Yao and Cooper, 1995; Kennedy et al., 1997; Kulik et al., 1997) . One likely downstream candidate for PI3K-mediated phosphorylation is the serine-threonine kinase c-Akt, an enzyme thought to directly couple cytokine signaling to the Bcl-2 family of proteins (reviewed in Gajewski and Thompson, 1996; Franke and Cantley, 1997; Kulik et al., 1997) as well as to the death effector caspase cascade (Cardone et al., 1998) . In agreement with these studies, pharmacologic inhibition of PI3K has been reported to abolish the antiapoptotic actions of SCF, LIF, and IGF-I in gonocytes of cultured fetal mouse ovaries (Morita et al., 1999a) . Interestingly, however, the effects of RA on oogonium and oocyte survival are not altered by PI3K inhibitors, suggesting the existence of multiple intracellular pathways responsible for transducing survival signals within the developing germline (Fig. 4) . The actions of RA on the fetal ovary are somewhat more complex to decipher than cytokine regulation since, unlike SCF, LIF, and IGF-I, which act principally as antiapoptotic factors (Morita et al., 1999a) , RA promotes both survival and proliferation of developing female gonocytes (Morita and Tilly, 1999) . The mitogenic response of oogonia to RA requires de novo gene expression,
FIG. 4.
Hypothetical intracellular map of the regulatory processes that determine the fate of the mouse female germline (see text for details and pertinent references). During murine fetal ovarian development, the survival or death of oogonia and oocytes is modulated by many extracellular stimuli, including survival factors (e.g., SCF, LIF, IGF-I, interleukin-1␤ (IL1␤)), retinoic acid (RA), and death factors (e.g., TGF␤). Survival factors utilize, among other messengers, phosphatidylinositol 3Ј-kinase (PI3K) to prevent apoptosis, possibly involving c-Akt phosphorylation and activation. In addition, based on recent observations (Nikolova-Karakashian et al., 1997) , IL1␤ may act via positive effects on ceramidase activity to generate the pro-survival molecule, sphingosine 1-phosphate (S1P), from ceramide substrates. In the absence of adequate survival factor support, intracellular death signals such as acid sphingomyelinase (ASMase)-generated ceramide may prevail to activate apoptosis. Whatever the initiating stimulus, signaling into mitochondria via Bcl-2 family members (e.g., Bcl-2, Bcl-w, Bcl-x L , Mtd/Bok, Bax) is probably central to the final decision made by the female germ cell to commit to or repress apoptosis execution. If apoptosis is the outcome, mitochondrial cytochrome c (cyt-c) release likely triggers the caspase cascade through Apaf-1 oligomerization. Note that the ability of RA to promote mitosis via activation of retinoic acid receptors (RAR) is restricted to oogonia (black arrows and text). Survival pathways are highlighted by blue arrows and text, whereas death pathways are highlighted by red arrows and text. most likely mediated via nuclear translocation of ligandactivated retinoic acid receptors (RAR) known to be expressed in the developing female germline, whereas the antiapoptotic effects of RA proceed completely independent of new macromolecular synthesis (Morita and Tilly, 1999) . Future studies of mice lacking functional expression of RA receptors and binding proteins, such as the RAR-␣ (Lufkin et al., 1993) and retinoid X receptor-␤ (Kastner et al., 1996) knockouts, which are already known to exhibit defects in spermatogenesis, may provide important genetic clarification of the mechanisms by which RA exerts its multifaceted actions within the female germline (Fig. 4) .
INTEGRATION OF THE OOCYTE DEATH SIGNAL: THE BCL-2 FAMILY AS A STOPCOCK
The first clue that Bcl-2, the founding member of this large family of anti-and proapoptotic molecules, functions in female germ cells was provided by a histomorphometric evaluation of ovaries collected from young adult bcl-2 gene knockout mice (Ratts et al., 1995) . Mutant females were found to possess a significantly reduced number of oocytecontaining primordial follicles compared with age-matched wild-type female mice, suggesting that Bcl-2 is at least one contributing piece to the puzzle of female germ cell death. This conclusion is consistent with the fact that significant amounts of Bcl-2 protein can be detected in e12.5 and e15.5 female mouse germ cells following in vitro culture without or with SCF (Pesce et al., 1997) and that polyadenylated bcl-2 mRNA transcripts are present in developing oocytes of the postnatal murine ovary . Nonetheless, it remained to be determined if Bcl-2 could directly repress apoptosis in the female germline. This postulate was recently confirmed in studies of female mice with targeted expression of human Bcl-2 only in oocytes that revealed marked resistance of transgenic oocytes to naturally occurring and toxicant-induced apoptosis (Morita et al., 1999b) .
Further evidence that Bcl-2 family members function as key determinants of germ cell fate is derived from studies of enforced expression of a second antiapoptotic molecule, Bcl-x L , in PGC collected from e11.5 mouse gonads (Watanabe et al., 1997) . Despite the fact that mouse gonads are not distinguishable as male versus female at this stage of embryogenesis (and thus, no conclusions are drawn about female germ cells per se), the data clearly show that loss of PGC in culture can be retarded by transfection with bcl-x L (or a viral antiapoptotic gene homologous to bcl-2 termed E1B-19K). Based on the reportedly high levels of polyadenylated bcl-x mRNA transcripts in murine oocytes , it is quite likely that, like PGC, Bcl-x L functions in the molecular program of oocyte survival. Unfortunately, mice possessing a targeted disruption of the bcl-x gene die very early in fetal development (Motoyama et al., 1995) , and thus some type of conditional knockout of the bcl-x gene in only the germline will be required to directly test the requirement of Bcl-x L in regulating oocyte fate. More recent investigations derived from analysis of bax-mutant (Ϫ/Ϫ) female mice have provided the first clues that proapoptotic members of the Bcl-2 family are functionally important in oocytes as well ; however, since the defects in oocyte apoptosis conveyed by Bax-deficiency appear to be most prominent in postnatal life, these discussions will be expanded below (see "Postnatal Oocyte Loss" and "Premature Ovarian Failure"). Little else is currently known of the function of other Bcl-2 family members in oocyte demise. However, based on findings that murine oocytes possess polyadenylated bcl-w mRNA transcripts , ongoing analysis of ovaries from bcl-w-null female mice may prove informative , particularly in light of the failed gametogenesis reported in Bcl-w-deficient males (Ross et al., 1998; Print et al., 1998) .
Before concluding this section, it is important to also note that a very recent series of elegant genetic studies of cell death during oogenesis in C. elegans has provided important clues as to the evolutionary conservation of the factors responsible for determining oocyte fate (Gumienny et al., 1999) . Interestingly, CED-9 loss of function was found to cause massive programmed death in the germline, consistent with the reported requirement for CED-9 in C. elegans somatic cell survival (Hengartner, 1996; Metzstein et al., 1998) . By comparison, oogenesis was unaffected in Egl-1 mutants (Gumienny et al., 1999) , dramatically contrasting the excessive somatic cell survival noted in Egl-1-deficient worms (Conradt and Horvitz, 1998) . Therefore, naturally occurring developmental cell death during oogenesis may be more acutely regulated by the actions of antiapoptotic (CED-9 in C. elegans; Bcl-2, Bcl-w, or Bcl-x L in vertebrates), as opposed to proapoptotic (Egl-1 in C. elegans; Bax in vertebrates), molecules that comprise this central integration step in cell death signaling (Figs. 2  and 3 ).
EXECUTION OF OOCYTE DEATH: THE GRAIN OF SAND IS LOST FOREVER
As discussed earlier, caspases are considered primary executioners of apoptosis in diverse cell lineages and animal species (Thornberry and Lazebnik, 1998) . Not surprisingly, several caspase family members are known to be expressed in murine oocytes (Bergeron et al., 1998; Jurisicova et al., 1998) . From a genetic perspective, excess numbers of oocyte-containing primordial follicles are endowed in the ovaries of neonatal caspase-2-deficient female mice (Bergeron et al., 1998) , suggesting that at least this specific family member plays a prominent role in the effector stage of oocyte demise during development. In agreement with this, recent preliminary evidence generated from studies of cultured fetal mouse ovaries indicates that the timedependent occurrence of germ cell apoptosis initiated by serum starvation in vitro can be abrogated by inclusion of peptide inhibitors of caspases (zVAD-fmk, zDEVD-fmk) in the culture medium (Morita et al., 1999c) . Moreover, singlecell caspase activity assays, which rely on cleavage of fluorescent molecules from a specific caspase substrate that can be preloaded into cells, have confirmed activation of caspases in oogonia and oocytes of cultured fetal mouse ovaries during apoptosis (Morita et al., 1999c) . Unfortunately, little else is known of the role played by other caspase family members in germ cell death during vertebrate oogenesis, although the recent generation of additional caspase family member knockouts (for examples, see Kuida et al., 1996 Kuida et al., , 1998 should provide valuable new genetic tools to answer these questions.
It is noteworthy that in Drosophila, a caspase homolog termed DCP-1 has been implicated in normal nurse cell function required for oogenesis (McCall and Steller, 1998) . In each ovarian egg chamber of the fly, 15 germline-derived nurse cells are connected to each other and to a single oocyte via cytoplasmic bridges. During development of the egg, DCP-1-dependent death of the nurse cells, which transfer RNA, protein, and mitochondria to the oocyte just prior to their demise, must occur for the final steps of oogenesis to proceed (McCall and Steller, 1998) . This paradigm of programmed cell death, in which one population of germline-derived cells commits to apoptosis for the benefit of a single sister germline cell, underscores the significant and evolutionarily conserved role of caspases in oocyte development. This concept is further exemplified by recent work in C. elegans in which mutant worms lacking expression of CED-3, the C. elegans counterpart to caspases in vertebrates, exhibit reduced oocyte death during oogenesis (Gumienny et al., 1999) . Therefore, future genetic studies with these invertebrate model systems, as well as with genetic-null mouse models, should continue to unravel the mysteries of cell death in the female germline and establish what will likely be a blueprint for oocyte death conserved remarkably through evolution (Fig. 4) .
OOCYTE LOSS DURING POSTNATAL LIFE: THE CLOCK KEEPS TICKING
Survival of oocytes is a continuous battle, carried forward from the earliest stages of fetal ovarian development (see above) throughout adult life. As mentioned earlier, human females are provided with approximately 1 ϫ 10 6 oocytes at birth, a starting reserve that is further decimated by apoptosis to fewer than 4 ϫ 10 5 by puberty and to fewer than 1 ϫ 10 3 in the years immediately preceding ovarian senescence (on average, around age 50) (Richardson et al., 1987; Faddy et al., 1992; Wise et al., 1996) . Considering that a woman will generally ovulate a single egg during each monthly cycle, at most only 400 or so oocytes survive and advance to the point of ovulation in adult life. A quick calculation thus reveals that greater than 99.9% of the oocytes endowed in the human ovaries at birth face death as their ultimate fate, a process which, when completed, leads to exhaustion of the follicle reserve and the menopause (Fig.  1) . Discussions of postnatal oocyte loss in mammals, however, become somewhat more complicated since the process of germ cell depletion, referred to as follicular atresia, can be initiated as a direct consequence of oocyte apoptosis or as an indirect consequence of apoptosis of the supporting somatic (granulosa) cells that nourish and mature the oocyte throughout postnatal life. The latter instance of germ cell loss occurs in follicles that have already progressed through several developmental stages and thus can be considered atresia of maturing (late preantral to early antral) or fully ripened (preovulatory) follicles. Since this paradigm of ovarian cell turnover is primarily somatic in nature, the reader is referred elsewhere for comprehensive reviews of granulosa cell apoptosis during follicular atresia (Tilly, 1996 (Tilly, , 1998b Tilly and Robles, 1999) .
In the case of postnatal oocyte loss driven by intrinsic death mechanisms within the germ cell itself, in mammals this is observed in follicles of the quiescent primordial stockpile and at the earliest stages of development (i.e., primary, small preantral). Although these immature follicles also possess granulosa cells intimately associated with the oocyte, it is death of the oocyte (Fig. 5) , as opposed to the somatic cells, that triggers atretic degeneration and irreversible elimination of the follicle from the ovary (Baker, 1963; Gougeon, 1996; Perez et al., 1999a) . Additionally, the negative impact of this paradigm of oocyte death on the female biological clock may actually worsen with age based on a number of observations in women that the rate of follicle atresia is accelerated in the years preceding the menopause (Richardson et al., 1987; Faddy et al., 1992) . Unfortunately, due to the technical difficulty in obtaining sufficient numbers of these populations of follicles for in-depth analysis, very little is known of the mechanisms responsible for initiating and executing apoptosis in oocytes of immature follicles. A single report has, however, offered the first and very exciting insights into this process and has provided the only example to our knowledge of a "slowing" of the female biological clock.
The culprit for these studies is the proapoptotic molecule Bax (Oltvai et al., 1993) , known to be expressed in both oocytes and somatic granulosa cells of the mammalian ovary Jurisicova et al., 1998; Kugu et al., 1998) . Although the first report of the creation of Baxdeficient mice indicated from histological assessments aberrant death of ovarian granulosa cells in females (Knudson et al., 1995) , further scrutiny of the ovaries of these animals revealed that the primordial follicle stockpile is enlarged threefold by around the time of puberty . These findings were somewhat of a puzzle since additional histomorphometric evaluations indicated that the oocyte reserve endowed at birth is identical in wild-type and knockout females. Only upon careful examination of the health status of the oocytes within the immature follicle pool was the basis for the surfeit of primordial follicles in young adult life explained (Fig. 5) , that being a marked reduction in the incidence of oocyte apoptosis and immature follicle atresia . Aside from providing the first proof that postnatal oocyte loss associated with atresia is genetically programmed, this report established another precedent in that the mouse equivalent of the menopause was delayed. In fact, bax-mutant female mice at 22 months of age, somewhere roughly equivalent to a 100-year-old woman, still retained hundreds of follicles at all developmental stages, including those responsible for estrogen biosynthesis . Therefore, future studies that concentrate on atresia of immature follicles in the postnatal mammalian ovary, including analyses of other genetic-null mouse lines lacking expression of key apoptosis-regulatory molecules, are certainly needed to fully understand what makes the female biological clock tick.
SPONTANEOUS OOCYTE FRAGMENTATION IN VITRO: IS IT OR IS IT NOT APOPTOSIS?
The final paradigm of "natural" oocyte demise to be discussed before finishing with an example of pathologic germ cell death is the fate of the small proportion of eggs that beat the odds by surviving to complete their developmental program of growth, maturation, and ovulation only to find there is no male gamete waiting to initiate fertilization and embryogenesis. Scant data exist on the fate of ovulated eggs, in vivo, that are not fertilized; however, in all likelihood these cells simply degenerate in the reproductive tract and disappear without incident over time. Some insight into this phenomenon may be derived from assessing the consequences of maintaining isolated mature oo- (primordial, primary, small preantral) follicles is driven by the induction of oocyte apoptosis, exemplified here by the fragmenting oocyte in the follicle on the left (arrow) compared with the healthy oocyte in the follicle on the right (asterisk). This figure was reproduced with permission (Nature America) from Perez et al. (1999a). cytes ex vivo. One of the first reports on this topic was provided by Takase et al. (1995) who concluded that apoptosis, as defined by both morphological criteria and in situ analysis of DNA cleavage, is the mechanism responsible for degeneration of unfertilized murine oocytes cultured in vitro. This general observation, and the overall conclusion, were followed in succession by similar experimental findings from other laboratories (Fujino et al., 1996; .
However, the idea that apoptosis is the mechanism by which ex vivo oocyte fragmentation is mediated was then challenged by a series of studies that failed to show any correlation between two reported biochemical markers of apoptosis (DNA cleavage and phosphatidylserine exposure on the outer leaflet of the plasma membrane) and fragmentation of murine or human oocytes in vitro (Van Blerkom and Davis, 1998) . The reasons for this discrepancy remain to be resolved. However, a detailed follow-up investigation, reaffirming that unfertilized murine oocytes maintained in vitro do in fact initiate a series of morphological and biochemical changes consistent with the occurrence of apoptosis, including cytoplasmic condensation, membrane budding, caspase activation, and DNA fragmentation (Fig.  6) , offers some possible explanations . Among these, it was stressed that diverse cell types appear to undergo apoptosis in subtly different ways. Therefore, scientists wishing to study apoptosis should consider, at least at the onset of such investigations, the use of several different assays to detect apoptosis since not all morphological or biochemical features may be displayed by a given FIG. 6. Morphological and biochemical features of murine oocyte death in vitro. Oocytes dying in vitro, either spontaneously or resulting from anticancer drug treatment, initiate a series of events consistent with the occurrence of apoptosis. These include cellular condensation, budding and fragmentation (B), caspase activation as assessed by cleavage of rhodamine from a caspase substrate peptide (D, intense red fluorescence), and DNA cleavage as detected by 3Ј-end labeling of DNA fragments with fluorescent deoxynucleotides (F, intense green fluorescence). By comparison, intact oocytes do not exhibit any of these features (A, C, and E, respectively). These data were reconfigured and then reproduced with permission (Oxford University Press) from Perez et al. (1999b). cell undergoing this form of death. In addition, the recent demonstration that spontaneous oocyte fragmentation in vitro is inhibited by overexpression of a classic antiapoptotic molecule (i.e., Bcl-2; Morita et al., 1999b) further supports the hypothesis that this paradigm of oocyte demise is indeed apoptosis.
PREMATURE OVARIAN FAILURE: THE STOPCOCK IS FURTHER LOOSENED
Up to this point, essentially all of the discussions have focused on the events surrounding normal oocyte loss via apoptosis in the context of either fetal or postnatal ovarian development. However, as hinted at in the Introduction and as indicated in Fig. 2 , apoptosis can be initiated by pathological insults as well. This is of critical importance in the context of oocyte depletion since the rate at which the female biological clock ticks can be dramatically accelerated by exposure of the ovaries to noxious agents (Tilly, 1998a) . For example, subfertility, if not sterility, and premature menopause are known to occur in young girls and reproductive-age women following treatment for cancer with either chemicals or radiation (Waxman, 1983; Familiari et al., 1993; Reichman and Green, 1994; Ried and Jaffe, 1994; Tilly and Johnson, 1999) . Although one can deduce from the discussions above that the female germline takes the brunt of this unfortunate side effect of cancer therapy, only recently has the issue of inappropriate oocyte apoptosis been directly tested as a potential mechanism. Using female mice as an experimental model (since female mice, like women, are known to respond to chemotherapeutic drugs with oocyte toxicity and ovarian failure; Takizawa et al., 1989; Shima, 1994) , it was shown that oocytes exposed either in vivo or in vitro to the classic chemotherapeutic drug, doxorubicin (Adriamycin, 14-hydroxydaunomycin), undergo apoptosis .
Of greater significance, several discrete apoptosisregulatory molecules have been identified as necessary for murine oocyte death initiated by chemotherapy, while others were found to be dispensable. For example, culture of oocytes with sphingosine 1-phosphate, a naturally occurring metabolite of ceramide and inhibitor of ceramidepromoted stress kinase activation and apoptosis (Cuvillier et al., 1996; Spiegel et al., 1998) , antagonizes oocyte apoptosis induced by doxorubicin . These findings, which imply a functional role for ceramide as an early proapoptotic signal generated in oocytes by anticancer drug exposure, are in agreement with the reported function of ceramide as a mediator of daunomycin-induced tumor cell death (Bose et al., 1995; Jaffrezou et al., 1996) . It is hoped that current efforts to explore the impact of knocking out acid sphingomyelinase (Horinouchi et al., 1995) , a hydrolytic enzyme responsible for ceramide generation from plasma membrane lipids (Kolesnick and Kronke, 1998) , on chemotherapy-induced ovarian failure in female mice (Y. Morita, G. I. Perez, S. Miranda, D. Ehleiter, E. H. Schuchman, R. N. Kolesnick, and J. L. Tilly, unpublished observations) will provide important genetic confirmation of data obtained with sphingosine 1-phosphatemediated inhibition of germ cell death. By comparison, oocytes obtained from female mice harboring a targeted disruption in the gene encoding a second primary signaling molecule known to be associated with cell death induction, namely p53, are as sensitive to doxorubicin-induced apoptosis as their wild-type counterparts . These observations starkly contrast the reported requirement for p53 in various paradigms of tumor cell death induced by antineoplastic drugs (Ding and Fisher, 1998) , underscoring the fact that various cell lineages, even responding to the same stimulus, can and do use a variety of early signaling molecules to accomplish the same goal, i.e., the activation of apoptosis.
Once the death signal has been propagated in murine oocytes by chemotherapy, it clearly appears to funnel through Bax as a central integrator since Bax-deficient oocytes are resistant to apoptosis induced by doxorubicin, both in vivo and in vitro . These observations are key for two reasons: first, the pathways governing oocyte fate during development appear to also function as primary determinants of germ cell death following pathologic insults, and second, targeting Bax for inactivation in oocytes may provide a novel approach to overcoming ovarian failure in female cancer patients. Regarding the latter, recent efforts to target expression of the Bax-neutralizing molecule, Bcl-2, only in oocytes have confirmed that this technology is indeed feasible and that oocyte-specific protection from chemotherapy-induced destruction can be achieved, at least in female mice (Morita et al., 1999b) .
Finally, and perhaps as expected based on molecular ordering studies of cell death-regulatory molecules in other systems, caspases appear to function as the death effector molecules in chemotherapy-induced germ cell destruction. Evidence for this comes from three sets of experiments, the first of which employed specific and irreversible small peptide inhibitors of caspases to prevent doxorubicininitiated oocyte fragmentation in vitro . Although these peptide inhibitors show wide crossreactivity with many different caspases, a subsequent assessment of the apoptotic response in caspase-2-deficient oocytes following chemotherapy exposure confirmed that at least this one family member is central to germ cell demise (Bergeron et al., 1998) . The third piece of evidence indicting caspases as executioners of oocytes comes from a very recent series of single-cell caspase activity assays which revealed that caspases are indeed activated in oocytes prior to the cascade of morphological changes associated with apoptotic death (Fig. 6) . These final observations are in agreement with the reported role of caspases in cleaving specific molecules to produce many of the biochemical and morphological features of apoptotic cell death (Cryns and Yuan, 1998; Thornberry and Lazebnik, 1998 ) and therefore help establish in oocytes a temporal framework of events leading to apoptosis.
CONCLUDING REMARKS AND FUTURE DIRECTIONS
Although considered by many to be an immutable law of nature, the incessant ticking of the female biological clock may, based on the studies discussed above, actually be amenable to manipulation with dramatic consequences for extending ovarian life span and maintaining fertility under conditions not normally conducive to such outcomes. Despite the exciting progress made over the just the past few years in understanding not only the occurrence and consequences of apoptosis in the female germline but the genetic regulation of the phenomenon, there remain many unanswered questions that will serve as ripe seeds for future research harvesting and application. For example, why do so may germ cells die off in females before birth? Hypotheses ranging from inadequate survival factor support from surrounding somatic cell lineages (Tilly, 1996; Pesce et al., 1997) to abnormalities in meiotic pairing events (Speed, 1988; Mittwoch and Mahadevaiah, 1992) have been put forth to explain the basis of prenatal oocyte death. Some surprises have surfaced as well, with one notable example being the impact of knocking out the ataxia-telangiectasia (AT-mutated or ATM) gene on gametogenesis. Believed to encode a protein principally involved in the cellular DNA damage response, such as that elicited by radiation (Westphal, 1997; Taylor, 1998) , ATM-deficient mice show postnatal sterility due to massive apoptosis of germ cells at prophase I of meiosis (Barlow et al., 1998) . Although not completely understood at present, it may be that ATM is critical for maintaining survival of germ cells during meiotic recombination events that involve DNA strand breaks.
A second intriguing question concerns the relationship between oocyte apoptosis and premature ovarian failure, the latter of which extends far beyond infertility associated with cancer treatment since early menopause is known to strike some women well before the normal time of ovarian quiescence for as yet unknown reasons. One prediction would be that key apoptosis-regulatory genes are aberrantly overexpressed (proapoptotic genes) or not expressed (antiapoptotic genes) in female germ cells during ovarian development, thus creating a situation in which the starting oocyte reserve is compromised prior to or from the time of birth. Of course, accelerated depletion of a normal follicle stockpile through atresia could also result in inappropriate wastage of oocytes, hastening the time to menopause. With the accumulating evidence from gene knockout mice identifying specific apoptosis-regulatory molecules as crucial for normal germ cell dynamics in the female, future assessments of these genes in the context of premature ovarian failure may prove revealing. These studies may be further assisted by investigations of other key cell deathcontrolling genes in germ cells, in particular the possible role played by the CED-4 homolog, Apaf-1, in mediating death signals within oocytes. The availability of mice lacking expression of functional Apaf-1 (Cecconi et al., 1998; Yoshida et al., 1998) , coupled with recent evidence for developmentally regulated expression of Apaf-1 in the murine ovary (Robles et al., 1999b) and for the functional requirement for CED-4 in C. elegans germline death (Gumienny et al., 1999) , make this particular example an attractive possibility for in-depth study.
In conclusion, it is clear that the female germline represents a relatively new and very dynamic model system for studying the actions and interactions of the various components of a cell death pathway remarkably conserved through evolution. In this review, we sought to provide a comprehensive evaluation of the literature regarding oocyte apoptosis as a means to explain the molecular and genetic basis of the female biological clock. Just as each grain of sand passes from the upper to the lower reservoir of an hourglass, at a rate predetermined by the diameter of the funnel separating the two compartments, oocytes are lost from the ovary at a rate which directly impacts on the functional life span of the female gonads. However, unlike the grains of sand in an hourglass, the data discussed herein collectively demonstrate that the rate of oocyte depletion is subject to manipulation by many genetic and pharmacological approaches. The prospects for controlling the rate at which oocytes commit themselves to death are enormous, with preserving ovarian function in female cancer patients Reynolds, 1999) to delaying the natural menopause in women offered as prime examples. Although more work is certainly needed before any clinical application can be considered, we can only hope that future research progress in the area of oocyte death will be swift. After all, the clock is ticking.
